May & Baker Nigeria Plc 2022 Abridged Results

May & Baker Nigeria Plc ( 2022 Abridged Report

By Published On: January 30, 2023TYPE: Abridged ReportsYear: 2022Period: Country: NigeriaSector: Pharmaceuticals

May & Baker Nigeria Plc ( listed on the Nigerian Stock Exchange under the Pharmaceuticals sector has released it’s 2022 abridged results.

For more information about May & Baker Nigeria Plc ( reports, abridged reports, interim earnings results and earnings presentations visit the May & Baker Nigeria Plc ( company page on AfricanFinancials.

Indicative Share Trading Liquidity

The total indicative share trading liquidity for May & Baker Nigeria Plc ( in the past 12 months, as of 3rd January 2023, is US$849.61K (NGN358.71M). An average of US$70.8K (NGN29.89M) per month.

May & Baker Nigeria Plc 2022 abridged results

Company Profile

May & Baker Nigeria Plc manufactures and markets a range of pharmaceuticals, vaccines, medical diagnostics, foods and consumer healthcare products in Nigeria. Pharmaceutical products include anti-diabetics, anti-infectives, anti-malaria, analgesics, cough & cold treatments, multivitamins and anxiolytics. May & Bake Nigeria Plc produce a range of Mimee noodles and Lily still water. The company’s head office is in Lagos, Nigeria. May & Baker Nigeria Plc is listed on the Nigerian Stock Exchange